CD4 and colitis: We also demonstrated that inhibition of IL-12/IL-23-mediated signaling, using anti-p40 antibodies, was sufficient to attenuate colitis severity in TAGAP-deficient mice, suggesting that colitogenic CD4+ T cells critically mediate the severe colitis phenotype seen in TAGAP deficiency.